CLOV vs IOVA · rev $1.37B vs rev $164.1M
Clover Health Investments Corp (CLOV) versus Iovance Biotherapeutics Inc (IOVA) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Iovance Biotherapeutics Inc (IOVA) is a biotechnology company listed on US.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported IOVA revenue for 2024-12-31 was $164.1M. Net income was -$372.2M. Revenue was up 13699.0% from 2023-12-31 to 2024-12-31. IOVA currently screens at market cap $1.89B.
CLOV currently screens at market cap $1.55B. IOVA currently screens at market cap $1.89B.
Not investment advice. Open the CLOV and IOVA stock pages for the full models.
Not investment advice.